Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 23% ± 9% | |
astrocyte | 5 studies | 22% ± 5% | |
microglial cell | 4 studies | 21% ± 4% | |
epithelial cell | 4 studies | 23% ± 5% | |
GABAergic neuron | 4 studies | 28% ± 8% | |
glutamatergic neuron | 4 studies | 34% ± 12% | |
macrophage | 4 studies | 21% ± 2% | |
oligodendrocyte | 4 studies | 20% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 5% | |
dendritic cell | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1876.26 | 1445 / 1445 | 100% | 16.99 | 183 / 183 |
ovary | 100% | 2834.89 | 180 / 180 | 100% | 21.69 | 430 / 430 |
lung | 100% | 2163.23 | 578 / 578 | 100% | 15.38 | 1151 / 1155 |
stomach | 100% | 1653.89 | 359 / 359 | 100% | 13.60 | 285 / 286 |
intestine | 100% | 2291.87 | 966 / 966 | 100% | 12.48 | 525 / 527 |
breast | 100% | 2416.91 | 459 / 459 | 99% | 20.91 | 1110 / 1118 |
skin | 100% | 2348.90 | 1809 / 1809 | 99% | 18.35 | 467 / 472 |
bladder | 100% | 2288.81 | 21 / 21 | 98% | 12.89 | 496 / 504 |
brain | 98% | 1190.67 | 2592 / 2642 | 100% | 15.92 | 704 / 705 |
pancreas | 100% | 1383.01 | 327 / 328 | 98% | 10.66 | 174 / 178 |
thymus | 100% | 2694.99 | 653 / 653 | 97% | 11.58 | 589 / 605 |
uterus | 100% | 2776.14 | 170 / 170 | 97% | 13.33 | 444 / 459 |
prostate | 100% | 2164.19 | 245 / 245 | 96% | 10.73 | 483 / 502 |
kidney | 100% | 1563.48 | 89 / 89 | 95% | 11.49 | 857 / 901 |
liver | 100% | 980.93 | 226 / 226 | 91% | 9.25 | 368 / 406 |
adrenal gland | 100% | 1869.88 | 258 / 258 | 85% | 6.19 | 195 / 230 |
adipose | 100% | 2172.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1859.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1575.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3039.37 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.15 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 12.75 | 79 / 80 |
peripheral blood | 98% | 1870.30 | 906 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 941.98 | 830 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.27 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 12.28 | 27 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO_0032259 | Biological process | methylation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0090309 | Biological process | positive regulation of DNA methylation-dependent heterochromatin formation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0070828 | Biological process | heterochromatin organization |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0140949 | Molecular function | histone H3K9 trimethyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0046974 | Molecular function | histone H3K9 methyltransferase activity |
GO_0140947 | Molecular function | histone H3K9me2 methyltransferase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0140948 | Molecular function | histone H3K9 monomethyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SETDB1 |
Protein name | SET domain bifurcated histone lysine methyltransferase 1 Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1) SET domain bifurcated histone lysine methyltransferase 1 (SET domain, bifurcated 1, isoform CRA_c) |
Synonyms | KIAA0067 KMT1E hCG_39375 ESET |
Description | FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3. H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes. H3 'Lys-9' trimethylation is coordinated with DNA methylation . Required for HUSH-mediated heterochromatin formation and gene silencing. Forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation . Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1 . SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells . Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) . In ESCs, in collaboration with TRIM28, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (By similarity). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing . The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions . . |
Accessions | E9PAP1 ENST00000525956.5 E9PQM8 A0A8I5KT93 ENST00000423081.1 ENST00000368962.6 [Q15047-2] ENST00000692314.1 X6RHV1 ENST00000534805.5 Q15047 ENST00000368963.5 B0QZE6 X6R732 ENST00000498193.5 ENST00000692827.1 E9PS59 ENST00000271640.9 [Q15047-1] ENST00000448029.5 ENST00000368969.8 [Q15047-3] E9PRF4 ENST00000368964.3 |